(2-12-20) USA: Former FDA Commissioner, “In total, 80% of the U.S. Supply of Antibiotics are Made in China…”

Former FDA Commissioner, “In total, 80% of the U.S. Supply of Antibiotics are Made in China…”

On February 12th, 2020, Scott Gottlieb—physician and former FDA commissioner under Trump’s administration— testified before the Senate Committee on Homeland Security and Governmental Affairs:


“[In 2019], manufacturing of intermediate or finished goods in China, as well as pharmaceutical source material, accounted for 95 percent of U.S. imports of ibuprofen, 91 percent of U.S. imports of hydrocortisone, 70 percent of U.S. imports of acetaminophen, 40 to 45 percent of U.S. imports of penicillin, and 40 percent of U.S. imports of heparin, according to the Commerce Department. In total, 80 percent of the U.S. supply of antibiotics are made in China…

aei.org

—Salt—-

“Faithful are the wounds of a friend, but the kisses of an enemy are deceitful.”

—Proverbs 27:6

Lack of data integrity in China presents challenges for U.S. and Chinese health regulators. In 2016, the China Food and Drug Administration investigated 1,622 drug clinical trial programs and canceled 80 percent of these drug applications after it found evidence of fraudulent data reporting and submissions of incomplete data, among other problems.


— (Extract) 2019 REPORT TO CONGRESS
of the U.S.- CHINA ECONOMIC AND SECURITY REVIEW COMMISSION: 
SECTION 3: GROWING U.S. RELIANCE ON CHINA’S
BIOTECH AND PHARMACEUTICAL PRODU
CTS

As a result of U.S. dependence on Chinese supply and the lack of effective health and safety regulation of Chinese producers, the American public, including its armed forces, are at risk of exposure to contaminated and dangerous medicines. Should Beijing opt to use U.S. dependence on China as an economic weapon and cut supplies of critical drugs, it would have a serious effect on the health of U.S. consumers.

— (Extract) 2019 REPORT TO CONGRESS
of the U.S.- CHINA ECONOMIC AND SECURITY REVIEW COMMISSION: 
SECTION 3: GROWING U.S. RELIANCE ON CHINA’S
BIOTECH AND PHARMACEUTICAL PRODUCTS

“Medicines Can Be Used as a Strategic and Tactical Weapon Against the United States…”

— Rosemary Gibson (July 31, 2019)
Senior Advisor of The Hastings Center,
(Extract) Testimony before the U.S.-China Economic and Security Review Commission

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s